Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
measles
Research
New antibodies stop measles from stabbing cells, study finds
Though a safe and effective vaccine for measles exists, other options are still needed for those who can't be given the shot.
Darren Incorvaia
May 7, 2026 11:00am
Jay Bhattacharya faces Senate grilling on NIH disruptions
Feb 3, 2026 5:20pm
'Why We Vaccinate': BIO targets lawmakers for immunization push
Oct 20, 2025 1:50pm
As measles surges, the first treatment remains a pipe dream
Jul 17, 2025 2:02pm
Ex-FDA leader joins new initiative aiming to protect vaccine use
Apr 24, 2025 1:18pm
NIH allegedly cancels grants for vaccine hesitancy research
Mar 13, 2025 11:49am
